[CITATION][C] Neuropeptide receptor imaging of schwannoma

H Van Steelandt, F De Geeter… - Journal of Nuclear …, 1996 - Soc Nuclear Med
Origin of Janus NeuropeptideReceptorImagingof Schwannoma Page 1 —,@ @ -_j:@ @ I @ @â€I
frequentlyused in its radiolabeledform for nuclear imaging. The absence of immunoreactivityon …

[PDF][PDF] Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging

JC Reubi - Journal of nuclear medicine, 1995 - Soc Nuclear Med
(5). Thereis, however, extensiveevidencethatshowsthatmost, if not all, of these
neuropeptides are also synthesized and act in non-neuronal tissues. The gut, with the brain …

Somatostatin receptors in schwannomas

JC Reubi - The Journal of Nuclear Medicine, 1997 - search.proquest.com
TO THE EDITOR: In a recent letter to the Editor, van Steelandt et al.(I) reported that they
were able to detect somatostatin receptors in schwannomas using an indirect in vitro …

Radiopeptide imaging and therapy in Europe

V Ambrosini, M Fani, S Fanti, F Forrer… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Receptor targeting with radiolabeled peptides has become an important topic, particularly in
nuclear oncology. Strong research efforts are under way in radiopharmaceutical science …

Neuroendocrine tumors

L Bodei, G Boni, G Paganelli, D Volterrani - … : Pathophysiology and Clinical …, 2013 - Springer
Neuroendocrine tumors (NETs) originate from single or clustered neuroendocrine cells,
distributed in the gastrointestinal tract, urogenital tract, endocrine, and bronchopulmonary …

Update on nuclear medicine imaging of neuroendocrine tumors

SJ Goldsmith - 2009 - Future Medicine
Radiolabeled tracers provide a functional imaging technique to identify neuroendocrine
tumors, usually with greater sensitivity and specificity than anatomic imaging techniques …

[HTML][HTML] Nuclear medicine imaging and therapy of neuroendocrine tumours

M Gotthardt, I Dijkgraaf, OC Boerman, WJG Oyen - Cancer Imaging, 2006 - ncbi.nlm.nih.gov
Radiolabelled peptides are used for specific targeting of receptors (over-) expressed by
tumour cells. Dependent on the kind of labelling and the radionuclide used, these …

[BOOK][B] Diagnostic and therapeutic nuclear medicine for neuroendocrine tumors

K Pacak, D Taïeb - 2016 - Springer
Diagnostic and therapeutic nuclear medicine for neuroendocrine tumors Series Editor: Leonid
Poretsky Contemporary Endocrinology Karel Pacak David Taïeb Editors Diagnostic and …

[PDF][PDF] Peptide receptor radionuclide therapy with 177Lu-DOTATATE in a case of concurrent neuroendocrine tumors and meningioma: achieving two things in a single …

M Assadi, SJ Rekabpour, A Amini… - Molecular Imaging …, 2021 - pdfs.semanticscholar.org
We present a partial response of peptide receptor radionuclide therapy (PRRT) with 177Lu-
DOTATATE in a case of concurrent neuroendocrine tumors (NETs) and meningioma. In …

Neuro-ectodermal tumours

CA Hoefnagel - Clinical Nuclear Medicine, 1998 - Springer
Since its first reported use in humans in 1981 [1], 131 I-meta-iodobenzylguanidine (MIBG)
has been used with success for the scintigraphic diagnosis of a variety of neuroendocrine …